Publications by authors named "Paul F Kantor"

Claim this Profile
E
Efficacy and Safety of Aficamten in Children and Adolescents With Obstructive Hypertrophic Cardiomyopathy: Study Design and Rationale of CEDAR-HCM.
Juan Pablo Kaski, Paul F Kantor, Stephanie J Nakano, Iacopo Olivotto, Mark W Russell

Circ Heart Fail· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiomyopathy-Associated Pathogenic Variants in Pediatric Myocarditis: A Study From the Pediatric Cardiomyopathy Registry.
Alicia M Kamsheh, Stephanie M Ware, Surbhi Bhatnagar, Lisa J Martin, Teresa M Lee, Paul F Kantor

Circ Heart Fail· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk stratification for sudden cardiac death in children with hypertrophic cardiomyopathy: A survey study.
Seshadri Balaji, Paul F Kantor, Reza Nezafat, Lars Grosse-Wortmann

Heart Rhythm· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between NT-proBNP changes and clinical outcomes in paediatric patients with heart failure: Insights from PANORAMA-HF and PARADIGM-HF.
Robert Shaddy, Jianjian Gong, Tania Garito, Susan Solar-Yohay, Sijia Zhang, Paul F Kantor

ESC Heart Fail· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling right and left ventricular adaptation over time after tetralogy of Fallot repair and the need for pulmonary valve replacement in adolescence.
Karla L Loss, John Wood, Jon A Detterich, Ramon Durazo-Arvizu, Luke M Wiggins, Paul F Kantor

Cardiol Young· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Testing Resources and Practice Patterns Among Pediatric Cardiomyopathy Programs.
Justin Godown, Emily H Kim, Melanie D Everitt, Wendy K Chung, Irene D Lytrivi, Paul F Kantor

Pediatr Cardiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of MEK Inhibition on Childhood RASopathy-Associated Hypertrophic Cardiomyopathy.
Cordula M Wolf, Martin Zenker, Olga Boleti, Gabrielle Norrish, Mark Russell, Paul F Kantor

JACC Basic Transl Sci· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sacubitril/Valsartan in Pediatric Heart Failure (PANORAMA-HF): A Randomized, Multicenter, Double-Blind Trial.
Robert Shaddy, Michael Burch, Paul F Kantor, Susan Solar-Yohay, Tania Garito

Circulation· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Serial B-Type Natriuretic Peptide Levels, Vasoactive Drug Weaning, and Adverse Cardiovascular Outcomes in Pediatric Heart Failure.
Karla L Loss, Jennifer Su, JonDavid Menteer, Molly A Weisert, Robert E Shaddy, Paul F Kantor

J Am Heart Assoc· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shedding Light on the Darkness of MYH7 Cardiomyopathies.
Paul F Kantor

JACC Heart Fail· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progressive Left Ventricular Remodeling for Predicting Mortality in Children With Dilated Cardiomyopathy: The Pediatric Cardiomyopathy Registry.
Paul F Kantor, Ling Shi, Steven D Colan, E John Orav, James D Wilkinson

J Am Heart Assoc· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac imaging and biomarkers for assessing myocardial fibrosis in children with hypertrophic cardiomyopathy.
Sonya Kirmani, Pamela K Woodard, Ling Shi, Taye H Hamza, Charles E Canter, Paul F Kantor

Am Heart J· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Characteristics of Pediatric Patients With Heart Failure Due to Systemic Left Ventricular Systolic Dysfunction in the PANORAMA-HF Trial.
Robert Shaddy, Michael Burch, Paul F Kantor, Susan Solar-Yohay, Tania Garito

Circ Heart Fail· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Sudden Death in Patients With RASopathy Hypertrophic Cardiomyopathy.
Aine Lynch, Mark Tatangelo, Sachin Ahuja, Chun-Po Steve Fan, Sandar Min, Paul F Kantor

J Am Coll Cardiol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy.
Jennifer Conway, Sandar Min, Chet Villa, Robert G Weintraub, Stephanie Nakano, Paul F Kantor

Circulation· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and impact of malnutrition in patients with Fontan physiology.
Ravneet Sekhon, Rae R Foshaug, Paul F Kantor, Gitanjali Mansukhani, Andrew S Mackie

JPEN J Parenter Enteral Nutr· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
QTc and QRS Abnormalities are Associated with Outcome in Pediatric Heart Failure.
Kandice Mah, Shiyi Chen, Gursimran Chandhoke, Paul F Kantor, Elizabeth Stephenson

Pediatr Cardiol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Treatment of Heart Failure in Children: Gaps and Opportunities.
Molly Weisert, Jennifer A Su, Jondavid Menteer, Robert E Shaddy, Paul F Kantor

Paediatr Drugs· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The genetic architecture of pediatric cardiomyopathy.
Stephanie M Ware, Surbhi Bhatnagar, Phillip J Dexheimer, James D Wilkinson, Arthi Sridhar, Paul F Kantor

Am J Hum Genet· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-invasive biomarkers of Fontan-associated liver disease.
Juliet Emamaullee, Sara Khan, Carly Weaver, Cameron Goldbeck, George Yanni, Paul F Kantor

JHEP Rep· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent and Upcoming Drug Therapies for Pediatric Heart Failure.
Karla L Loss, Robert E Shaddy, Paul F Kantor

Front Pediatr· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Causes of Cardiomyopathy in Children: First Results From the Pediatric Cardiomyopathy Genes Study.
Stephanie M Ware, James D Wilkinson, Muhammad Tariq, Jeffrey A Schubert, Arthi Sridhar, Paul F Kantor

J Am Heart Assoc· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visual Diagnosis: High Fever, Maculopapular Rash, Perianal Desquamation, and Conjunctivitis in a 3-year-old Boy.
Alexander K C Leung, Consolato Maria Sergi, Kin Fon Leong, Paul F Kantor, Md

Pediatr Rev· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response by Mital et al to Letter Regarding Article, "A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy".
Seema Mital, Katey R Armstrong, Ryan J Butts, Jennifer Conway, Steve Fan, Paul F Kantor

Circulation· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypertrophic Cardiomyopathy in Adolescence: Application of Guidelines.
Paul F Kantor, Timothy W Casarez, Yaniv Bar-Cohen

JACC Case Rep· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis